ABLATUS THERAPEUTICS LIMITED
NORWICH

Hellopages » Norfolk » Norwich » NR3 1RU

Company number 09812865
Status Active
Incorporation Date 7 October 2015
Company Type Private Limited Company
Address 1 ST JAMES COURT, WHITEFRIARS, NORWICH, NORFOLK, UNITED KINGDOM, NR3 1RU
Home Country United Kingdom
Nature of Business 72190 - Other research and experimental development on natural sciences and engineering
Phone, email, etc

Since the company registration ten events have happened. The last three records are Appointment of Professor Marcus Denis Flather as a director on 29 June 2016; Confirmation statement made on 6 October 2016 with updates; Second filing of a statement of capital following an allotment of shares on 5 April 2016 GBP 14.20 . The most likely internet sites of ABLATUS THERAPEUTICS LIMITED are www.ablatustherapeutics.co.uk, and www.ablatus-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is nine years and twelve months. Ablatus Therapeutics Limited is a Private Limited Company. The company registration number is 09812865. Ablatus Therapeutics Limited has been working since 07 October 2015. The present status of the company is Active. The registered address of Ablatus Therapeutics Limited is 1 St James Court Whitefriars Norwich Norfolk United Kingdom Nr3 1ru. . ALLAN, William David, Dr is a Director of the company. BLACKWOOD, Anne Dunlop, Dr is a Director of the company. BROOKS, David Graham, Dr is a Director of the company. FLATHER, Marcus Denis, Professor is a Director of the company. The company operates in "Other research and experimental development on natural sciences and engineering".


Current Directors

Director
ALLAN, William David, Dr
Appointed Date: 23 May 2016
67 years old
Director
BLACKWOOD, Anne Dunlop, Dr
Appointed Date: 07 October 2015
56 years old
Director
BROOKS, David Graham, Dr
Appointed Date: 07 October 2015
57 years old
Director
FLATHER, Marcus Denis, Professor
Appointed Date: 29 June 2016
67 years old

Persons With Significant Control

Health Enterprise East Ltd
Notified on: 6 April 2016
Nature of control: Ownership of shares – More than 25% but not more than 50%
Norfolk & Norwich University Hospital Nhs Foundation Trust
Notified on: 6 April 2016
Nature of control: Ownership of shares – More than 25% but not more than 50%

ABLATUS THERAPEUTICS LIMITED Events

26 Oct 2016
Appointment of Professor Marcus Denis Flather as a director on 29 June 2016
20 Oct 2016
Confirmation statement made on 6 October 2016 with updates
07 Sep 2016
Second filing of a statement of capital following an allotment of shares on 5 April 2016
  • GBP 14.20
01 Sep 2016
Statement of capital following an allotment of shares on 10 February 2016
  • GBP 10.75
03 Jul 2016
Current accounting period extended from 31 October 2016 to 31 December 2016
...
... and 0 more events
07 Jun 2016
Statement of capital following an allotment of shares on 30 March 2016
  • GBP 15.10
  • ANNOTATION Clarification a second filed SH01 was registered on 07/09/2016
07 Jun 2016
Appointment of Dr William David Allan as a director on 23 May 2016
13 Apr 2016
Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
06 Jan 2016
Registration of charge 098128650001, created on 17 December 2015
07 Oct 2015
Incorporation
Statement of capital on 2015-10-07
  • GBP 10
  • MODEL ARTICLES ‐ Model articles adopted

ABLATUS THERAPEUTICS LIMITED Charges

17 December 2015
Charge code 0981 2865 0001
Delivered: 6 January 2016
Status: Outstanding
Persons entitled: University of East Anglia, as Operator of the Low Carbon Innovation Fund
Description: Contains fixed charge…

Similar Companies

ABLATIVE HOSTING LIMITED ABLATIVE LIMITED ABLAYE LTD ABLAZE A BUSINESS LEARNING ACTION ZONE FOR EDUCATION ABLAZE BAKING SOLUTIONS LTD ABLAZE BUILDING SOLUTIONS LIMITED ABLAZE CARE SERVICES LTD